Parecoxib concerning safety failed to come back again in 10 years

Published: 2016-07-18 10:07:51

Updated: 2016-07-18 10:07:51

The Pfizer’s anti-inflammatory drug, ‘parecoxib(product name: dynastat),’ tried to enter the prescription market against its safety and efficacy issues again in 10 years, but finally failed.

The COX-2 inhibitor anti-inflammatory drug, parecoxib is a drug which practically got kicked out of the prescription market as being registered in the ‘List of Substances with Safety and Efficacy Issues’ d...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.